JP Morgan strategist Kolanovic continues to bet on U.S. stocks and becomes Wall Street’s only remaining big short

There is only one big short left among Wall Street’s stock market opinions. After Morgan Stanley’s Mike Wilson defected on Monday, only JPMorgan Chase’s Marko Kolanovic still maintains his pessimistic view on U.S. stocks.

Only one big short is left among Wall Street\’s stock market opinions. After Morgan Stanley\’s Mike Wilson defected on Monday, only JPMorgan Chase\’s Marko Kolanovic still maintains his pessimistic view on U.S. stocks.
Kolanovic reiterated his views in a note to clients late Monday, calling against buying stocks while acknowledging that this negative view has hurt JPMorgan\’s portfolio over the past year as global stocks rose to record highs. Configure the model.
He cited a series of reasons to remain bearish, including high valuations, the likelihood that interest rates will remain restrictive for longer, rising inflation data, consumer pressure and geopolitical uncertainty.
\”The negative stance on equities has hurt the performance of our multi-asset portfolio over the past year,\” Kolanovic acknowledged.
He also added: We do not currently view the stock as an attractive investment. We also do not see a reason to change our position.
Kolanovic is now the last dissident among the Wall Street bank\’s equity strategists after Morgan Stanley\’s Wilson turned bullish on U.S. stocks on Monday.
Wilson now expects the S&P 500 to rise to 5.400 by June 2025. This is a sharp reversal from his previous forecast of a 15% decline for the index by December.
Among the major Wall Street banks, JPMorgan Chase has the lowest year-end target for the S&P 500. It is only 4.200 points, implying more than 20% downside from Monday\’s closing price.
The second-lowest year-end target comes from Citigroup, which gives a forecast of 5.100, indicating that the market is likely to see a mild downside from current levels.
Goldman Sachs has a target of 5.200, also signaling that there is no more room to rise.
But neither the banks\’ top equity strategists, Scott Chronert or David Kostin, are warning that a big drop is coming, as is the JPMorgan team.
At the same time, Bank of America and Wells Fargo expect the S&P 500 index to rise further. The year-end target levels given are 5.400 points and 5.535 points respectively.
Both banks raised their initial forecasts as U.S. stocks continued to climb on the back of a strong economy and corporate earnings, as well as a continued rise in the AI ​​craze.
Kolanovic’s outlook for U.S. stocks has fallen short for the third consecutive year.
Despite his prediction of a decline, the S&P 500 is up 11% so far in 2024.
He was also bearish last year. But the stock market rose 24%.
He was bullish for much of 2022. The market fell 19% that year.

Like (0)
Previous May 21, 2024 4:04 pm
Next May 22, 2024 5:54 pm

Related posts

  • From new productive forces to breakthroughs in foreign trade, experts: These elements inject new vitality into China’s economy

    On April 23, the China Journalists Association held a press teahouse in Shanghai for the first time. Five experts from the Institute of World Economics and Politics, Chinese Academy of Social Sciences, interpreted the Chinese economy around current hot topics, such as new productivity and foreign investment.

    US Stocks Focus April 25, 2024
  • Martian (300894.SZ): Net profit in the first quarter was 36.8823 million yuan, a year-on-year decrease of 24.52%

    Gelonghui April 25丨Martian (300894.SZ) announced the first quarter report of 2024. The operating income during the reporting period was 348 million yuan, a year-on-year decrease of 15.44%; the net profit attributable to shareholders of the listed company was 36.8823 million yuan, a year-on-year decrease of 24.52%. %; net profit after non-recurring gains and losses attributable to shareholders of listed companies was 33.8044 million yuan, a year-on-year decrease of 18.07%; basic earnings per share was 0.09 yuan.

    US Stocks Focus April 25, 2024
  • Buzzing stocks.Stocks that will see action today: April 29, 2024

    Apollo HealthCo Limited, a subsidiary of Apollo Hospitals Enterprise Limited, has entered into a binding agreement to raise equity capital of ₹2,475 crore from Advent International, one of the world’s largest and most experienced global private equity investors. In addition, Apollo 24/7 has entered into a framework agreement to integrate 100% of Keimed Private Limited, India’s leading wholesale pharma distributor, in a phased manner over the next 24-30 months.

    US Stocks Focus April 29, 2024
  • Broker’s call: JSW Steel (Buy)

    Target: ₹1,070 CMP: ₹915.15 JSW Steel posted a consolidated revenue of ₹46,300 crore (-2% y-o-y/ +10 per cent q-o-q ; in line) in Q4-FY24. ASP stood at ₹68,750/t (-4 per cent y-o-y/-2 per cent q-o-q) vs. our est. of ₹67,507/t. Combined crude steel production was 6.79mt (+3 per cent y-o-y/-1 per cent q-o-q), while steel sales came in at 6.73mt (+3 per cent y-o-y/+12 per cent q-o-q) with capacity utilisation of 93 per cent at the Indian operations. JSTL India operations reported the highest ever VASP sales, up 5 per cent y-o-y (about 62 per cent share of total sales). During FY24, revenue grew 5 per cent to ₹1,75,000 crore led by robust volume growth. EBITDA/APAT stood at ₹28200 crore/₹9,000 crore. Consolidated crude steel production and sales volume stood at 26.4mt and 25mt, respectively. Going forward, we expect JSTL’s domestic volumes to be robust with increasing capacities, a better product mix, and export opportunities. Moreover, with stable pricing, softened coal costs, and improving operational efficiencies, we expect its EBITDA/t to improve going forward. We raise our revenue/EBITDA estimates by 2/5…

    US Stocks Focus May 23, 2024
  • LIC stock surges 5% after increasing stake in Dr Reddy’s Laboratories

    The stock of Life Insurance Corporation of India surged 5 per cent on Friday, a day after the corporation increased its shareholding in Dr Reddy’s Laboratories.

    US Stocks Focus June 18, 2024
  • Indegene IPO subscribed 69.70 times as institutions bid aggressively

    The initial public offering of Indegene saw a robust response from all category investors, as the issue was subscribed 69.70 times, thanks to QIBs.

    US Stocks Focus May 8, 2024